--- title: "GLP-1 Side Effects Week by Week | GLPMate" url: https://glpmate.me/learn/glp-1-side-effects-week-by-week language: en description: "When GLP-1 side effects start, peak and fade: nausea, constipation, fatigue and reflux mapped by titration week, plus clear doctor-call signs." updated: 2026-07-22 --- [GLP-1 guides](/learn) # GLP-1 side effects, week by week: what’s typical, what’s temporary, what’s a call-your-doctor Based on FDA prescribing information & peer-reviewed sources · Updated 2026-07-22 · 7 min read Quick answer Most GLP-1 side effects are gastrointestinal, mild-to-moderate, cluster around dose increases, and fade within days to a few weeks as your body adapts. In the STEP trial, nausea affected about 44% of semaglutide 2.4 mg users but led only ~4.5% to stop treatment. Severe or persistent pain, repeated vomiting or dehydration are different — those need a clinician, not patience. ## The big picture first GLP-1 side effects are mostly a story about your digestive system adapting to slower gastric emptying — and the adaptation is real. Trials and labels agree on the pattern: **gastrointestinal, early, dose-step-related, and usually transient**. **44%** of participants on semaglutide 2.4 mg reported nausea in STEP 1 — yet only ~4.5% stopped for GI side effects. Common ≠ unbearable, and most of it passes. ## Weeks 1–2: the introduction period On starter doses, many people feel little or nothing. When symptoms appear, it’s typically mild nausea or fatigue in the 24–72 hours after injecting — the window your level peaks. Small meals, slower eating and skipping heavy/fatty food on shot day are the standard first-line tactics. ## Weeks 3–6: dose steps and their echoes Each titration step (weeks 4, 8, 12…) tends to bring a short symptom echo — a few rougher days while your body meets the higher level, then settling. Constipation often surfaces in this window as food volume drops; fluids, fiber and movement are the label-consistent basics. Reflux and burping (“sulfur burps” for a minority) also cluster here. The practical skill in this phase is **separating step-echoes from trends**: a 6/10 nausea for two days after moving to 5 mg that fades to 2/10 is a normal echo. A 6/10 that stays 6/10 for two weeks is a conversation with your prescriber about pace. ## Weeks 6–12: the fade For most people, GI symptoms genuinely decline as doses stabilize — the trials’ event curves drop after the escalation phase. Appetite suppression stays; the queasiness mostly doesn’t. If your chart shows the opposite shape (rising severity at a stable dose), that’s exactly the kind of pattern worth showing a clinician early. ## What helps, per the labels and trial protocols - **Eat smaller, slower, earlier** — volume and speed drive most nausea. - **Hydrate deliberately** — dehydration is the quiet escalation path (and the kidney-warning route on the labels). - **Protein first, fiber daily** — protects muscle, manages constipation. - **Time heavy meals away from your peak** (days 1–3 post-shot). - **Ask about pacing** — holding a titration step longer is a labeled, normal move. ## The unambiguous “call your doctor now” list - Severe, persistent abdominal pain — especially radiating to the back (pancreatitis warning) - Repeated vomiting, inability to keep fluids down, or signs of dehydration - Right-upper-abdomen pain, fever, or yellowing skin/eyes (gallbladder warning) - Allergic-reaction signs: swelling of face/throat, trouble breathing - Severe hypoglycemia if you also take insulin or a sulfonylurea These come straight from the FDA labels’ warning sections. No app, ours included, is the right tool for them — a clinician is. ## Why tracking severity changes the conversation “Some nausea” gets you sympathy. “Nausea peaked at 6/10 for two days after each step, easing to 1–2/10 by day four — here’s the chart” gets you a _plan_: hold this step, adjust that habit, escalate on schedule. Ten seconds of logging per symptom buys you decision-grade appointments for the rest of your journey. **Severity beats memory** Log symptoms at 0–10 in GLPMate — by tap or by chat — and see them charted against your dose steps for your next appointment. [Track side effects free](/download) ## Sources 1. [Wilding et al., NEJM 2021 (STEP 1)](https://doi.org/10.1056/NEJMoa2032183) — nausea ~44%, diarrhea ~31.5%, discontinuation for GI events ~4.5% on semaglutide 2.4 mg 2. [Jastreboff et al., NEJM 2022 (SURMOUNT-1)](https://doi.org/10.1056/NEJMoa2206038) — GI events mostly mild-to-moderate, occurring primarily during escalation 3. FDA Prescribing Information — Wegovy / Zepbound ([Wegovy](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256), [Zepbound](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806)) — warnings: pancreatitis, gallbladder disease, dehydration/kidney injury This article is educational and is not medical advice, diagnosis or treatment. Medication decisions — including dose changes and what to do after a missed dose — belong with your prescriber. If you experience severe symptoms, seek medical care. ## Keep reading [The side-effect tracker (0–10 severity) ](/glp-1-side-effect-tracker)[Your first month, week by week ](/learn/first-month-on-glp-1)[Steady state, explained ](/learn/glp-1-steady-state-explained) ## Start your GLP-1 journey with a companion that listens. Free to start. iOS & Android. [ Download on the **App Store** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=learn-glp-1-side-effects-week-by-week&adj_redirect_android=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_macos=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_windows=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235) [ GET IT ON **Google Play** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=learn-glp-1-side-effects-week-by-week&adj_redirect_ios=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_macos=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_windows=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate)